Para acceder al artículo original haz clic aquí.

New Regulatory Approvals Support DAO Deficiency Solution Expansion
In February 2022, the active ingredient diamine oxidase – or DAO – produced by AB Biotek’s DR Healthcare division, as well as the solutions derived